July 28, 2021 09:30 AM EDTUpdated 09:43 AM

Covid-19 roundup: AstraZeneca publishes data on blood clots associated with vaccine; GlaxoSmithKline and Vir ink mAb supply deal with EU

Josh Sullivan

Zachary Brennan

Senior Editor

Thirteen cases of thrombosis with thrombocytopenia syndrome in recipients of the AstraZeneca Covid-19 vaccine have led to a number of countries pausing its authorization. On …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: AstraZeneca publishes data on blood clots associated with vaccine; GlaxoSmithKline and Vir ink mAb supply deal with EU

Josh Sullivan

Zachary Brennan

Senior Editor

Sign up to read this article for free.

After stock slides, Amgen addresses bone density talk on obesity drug

Metsera raises $215M for studies of GLP-1 and amylin obesity drugs

Adaptimmune's second T cell receptor cell therapy for rare sarcomas passes pivotal test

New cancer class heats up as BioNTech buys out China partner and its PD-L1/VEGF drug

J&J takes 340B fight with federal government to court

What Will It Take to Reverse Fibrosis in Patients with Advanced MASH?

Covid-19 roundup: As­traZeneca pub­lish­es da­ta on blood clots as­so­ci­at­ed with vac­cine; Glax­o­SmithK­line and Vir ink mAb sup­ply deal with EU

Senior Editor

Sign up to read this article for free.

Covid-19 roundup: AstraZeneca publishes data on blood clots associated with vaccine; GlaxoSmithKline and Vir ink mAb supply deal with EU